Book Online
Make a Booking

Meningococcal Vaccine Study

OVERVIEW

Several different germs can cause  serious infection of the blood and nervous system. A germ (bacterium) called te meningococcus, can cause several serious complications, including meningitis and infection of the blood. Meningitis affects the brain and spinal cord. It can cause hearing loss, seizures, learning and behaviour problems, severe brain damage and even death . Meningococcal disease, whilst a rare illness, can happen to anyone but is more common in teenagers, and young children (especially babies). This research study will help us learn about an experimental vaccine that might protect against diseases caused by different types of meningococcus germs (types A, B, C, W, Y).

An experimental vaccine has to be tested and approved by national health agencies before it can be marketed and given to people in the general community. Several studies are done to test an experimental vaccine. National health agencies look at the results of these studies and then decide whether to approve an experimental vaccine for use. All routine vaccines that you receive have been through this same process.

This study is being conducted to learn more about the safety and immune response of an experimental vaccine against types A, B, C, W and Y, in healthy adolescents and adults from 18 through 25 years of age.

THE INVESTIGATIONAL VACCINE

The MenABCWY vaccine has been developed based upon two already available vaccines. One is a vaccine that helps to protect against the meningococcus B germ. The other is a vaccine that helps protect against types A, C, W and Y of the meningococcus germ. The use of these two vaccines has been licensed in Australia for people from 2 months of age.

WHAT HAPPENS?

You will be required to come to our clinic 6 times, each visit you will see the study doctor and then the research team for vaccination or blood draw.

There is no cost for the vaccine or study visits, and you will be compensated for time and travel.

TO BE ELIGIBLE YOU MUST:

*please note, if you attended high school outside of Australia, you may not have had the vaccine and are potentially eligible.

PRINCIPAL INVESTIGATOR

A/Prof Mark Bloch

CONTACT US

Please contact Holdsworth House Research to register your interest:

Phone: 02 8038 1044

Email: studies@holdsworthhouse.com.au